Global Nuclear Medicine Imaging Equipment Market Research Report– Segmented by Modality (Single Photon Emission Computed Tomography (SPECT) Systems, Positron Emission Tomography (PET) Systems, Hybrid SPECT/CT Systems, Hybrid PET/CT Systems, Hybrid PET/MRI Systems, Others); by Detector Type (Scintillation Detectors, Solid-State Detectors, Others); by Application (Oncology, Cardiology, Neurology, Orthopedics, Others); by End-User (Hospitals, Diagnostic Imaging Centers, Academic & Research Institutes, Others); and Region Forecast (2026–2030).
GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET (2026 - 2030)
In 2025, the Global Nuclear Medicine Imaging Equipment Market was valued at approximately USD 3,965 Million and is projected to reach around USD 6,842 Million by 2030, expanding at a CAGR of about 11.5% during 2026–2030.
The market is witnessing strong growth due to increasing demand for advanced diagnostic imaging, rising prevalence of chronic diseases, and advancements in hybrid imaging technologies.
Nuclear medicine imaging equipment is used to visualize physiological functions within the body by detecting radiation emitted from radiopharmaceuticals. These imaging techniques, including SPECT and PET, are widely used in the diagnosis and management of diseases such as cancer, cardiovascular disorders, and neurological conditions. Unlike conventional imaging methods, nuclear imaging provides functional insights into organ systems, enabling early detection and accurate diagnosis.
The increasing incidence of cancer and cardiovascular diseases is a major driver of the market. Nuclear imaging plays a crucial role in oncology for tumor detection, staging, and treatment monitoring. In cardiology, these systems are used to assess blood flow and heart function, while in neurology, they assist in diagnosing disorders such as Alzheimer’s disease and epilepsy.
Technological advancements, particularly in hybrid imaging systems such as PET/CT and PET/MRI, are enhancing diagnostic accuracy and expanding clinical applications. These hybrid systems combine anatomical and functional imaging, allowing healthcare providers to obtain comprehensive diagnostic information. As healthcare systems increasingly adopt advanced imaging technologies, demand for nuclear medicine imaging equipment is expected to grow.
Key Market Insights
• Hybrid imaging technologies are becoming increasingly important for improving diagnostic accuracy.
• Oncology remains the largest application area for nuclear medicine imaging.
• Advances in detector technologies are improving image quality and scanning efficiency.
• Hospitals and diagnostic imaging centers are major end users of nuclear imaging equipment.
• Increasing adoption of PET and SPECT imaging is driving market growth.
• Around 40 million nuclear medicine procedures are performed globally each year, highlighting strong demand for imaging equipment.
• Technetium-99m is used in over 80% of nuclear medicine diagnostic procedures worldwide, supporting widespread SPECT usage.
• PET imaging is increasingly used in oncology, with millions of scans conducted annually for cancer diagnosis and monitoring.
• The global installed base of PET/CT systems continues to grow as hospitals upgrade to hybrid imaging technologies.
Research Methodology
Scope & Definitions
Covers SPECT, PET, and hybrid imaging systems across diagnostic applications; excludes radiopharmaceuticals and non-nuclear imaging modalities.
Geography: Global (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa); timeframe: 2020–2030 (base year: 2025).
Segmentation follows modality, detector type, application, and end-user; MECE structure with “Others” buckets.
Standardized data dictionary applied; revenues normalized to USD; double counting prevented by isolating equipment sales only.
Evidence Collection (Primary + Secondary)
Primary interviews across OEMs, distributors, hospital administrators, radiologists, and procurement heads.
Secondary sources include company filings, annual reports, investor presentations, and publications from WHO, IAEA, OECD, and peer-reviewed journals.
Uses verifiable, source-linked evidence within the report; additional inputs from relevant regulators/standards bodies/industry associations specific to Nuclear Medicine Imaging Equipment Market (named in-report).
Triangulation & Validation
Market sizing via bottom-up (unit shipments × ASP) and top-down (healthcare imaging spend allocation).
Cross-validated with financial disclosures of key players.
Conflicting inputs reconciled through weighted averaging, expert validation, and consistency checks across regions and segments.
Presentation & Auditability
All assumptions, models, and calculations are documented and reproducible.
Source-linked citations provided for key insights to ensure traceability.
Clear audit trail maintained for segmentation, forecasts, and methodology updates.
Market Drivers
The rising prevalence of cancer and chronic diseases is driving the market
The increasing global burden of cancer and other chronic diseases is significantly driving demand for nuclear medicine imaging equipment. These imaging technologies are widely used for early disease detection, staging, and monitoring treatment effectiveness. Nuclear imaging enables clinicians to identify disease at a molecular level, improving diagnostic accuracy and patient outcomes. In oncology, PET and SPECT imaging systems are essential tools for detecting tumors and evaluating cancer progression. Similarly, in cardiology and neurology, nuclear imaging provides valuable insights into organ function. As the incidence of chronic diseases continues to rise, demand for advanced imaging technologies is expected to increase.
Technological advancements in hybrid imaging systems are driving the market
The development of hybrid imaging systems such as PET/CT and PET/MRI is transforming the nuclear medicine imaging landscape. These systems combine functional imaging with anatomical imaging, providing comprehensive diagnostic information in a single scan. Advancements in detector technologies, image processing, and software integration are further enhancing the performance of nuclear imaging systems. These innovations are improving image resolution, reducing scan times, and enabling more accurate diagnoses. As healthcare providers adopt advanced imaging technologies, the demand for nuclear medicine imaging equipment is expected to grow.
Market Restraints
One of the key challenges in the Nuclear Medicine Imaging Equipment Market is the high cost associated with advanced imaging systems and infrastructure requirements. Installation of PET and SPECT systems requires significant capital investment, specialized facilities, and trained personnel. Additionally, regulatory requirements related to radiation safety and handling can increase operational complexity.
Market Opportunities
The increasing adoption of personalized medicine and molecular imaging presents significant opportunities for the nuclear medicine imaging equipment market. Advances in radiopharmaceuticals and imaging technologies are enabling more targeted and precise diagnostic approaches. Additionally, expanding healthcare infrastructure in emerging markets is creating new opportunities for the adoption of advanced imaging systems. Governments and healthcare organizations are investing in modern diagnostic facilities to improve healthcare outcomes, which is expected to drive demand for nuclear medicine imaging equipment.
How this market works end-to-end
Healthcare providers assess diagnostic gaps in oncology, cardiology, or neurology.
Clinical teams define required imaging capability, such as SPECT, PET, or hybrid systems.
Procurement evaluates modality options including standalone and hybrid configurations.
Detector type selection impacts image quality, speed, and long-term performance.
Vendors propose systems, often bundled with software and service contracts.
Installation planning includes shielding, compliance, and facility upgrades.
Systems are deployed in hospitals, imaging centers, or research institutes.
Workflow integration aligns imaging output with clinical decision systems.
Utilization rates determine ROI through scan volume and reimbursement cycles.
Upgrade or replacement decisions are triggered by performance gaps or new clinical needs.
Why this market matters now
The pressure is not just clinical. It is financial and operational.
Healthcare providers are balancing three forces at once: rising demand for precision diagnostics, constrained capital budgets, and rapid technology shifts. Hybrid systems are improving outcomes, but they also raise upfront costs and complexity.
At the same time, imaging is no longer a standalone function. It feeds into treatment planning, especially in oncology. That makes delays in upgrading equipment a strategic risk, not just a technical one.
There is also uncertainty in reimbursement and utilization. High-end systems require consistent patient volume to justify investment. In volatile healthcare environments, that volume is not guaranteed.
The real question is no longer “Should we invest?” but “When and how do we invest without locking into the wrong cycle?”
What matters most when evaluating claims in this market
Claim type
What good proof looks like
What often goes wrong
Performance improvement
Measured scan time reduction and image clarity gains
Vendor claims without clinical validation
ROI justification
Throughput data tied to actual patient volume
Overestimated utilization assumptions
Technology advantage
Clear differentiation in detector or hybrid capability
Marketing language without technical depth
Upgrade flexibility
Documented upgrade paths and software support
Hidden costs in future upgrades
Clinical impact
Evidence of improved diagnosis or treatment planning
Generic claims not tied to specific use cases
The decision lens
Define the clinical priority
Identify whether oncology, cardiology, or neurology drives demand. This shapes modality choice.
Compare modality pathways
Evaluate standalone vs hybrid systems based on long-term relevance, not short-term cost.
Assess technology lifecycle risk
Check how quickly current systems may become outdated due to detector or software shifts.
Examine vendor dependency
Understand integration, service contracts, and switching costs before committing.
Stress-test financial exposure
Model capex, maintenance, and upgrade costs under different demand scenarios.
Align with infrastructure readiness
Ensure facility, compliance, and staffing capabilities match the system requirements.
The contrarian view
Many buyers assume that the most advanced system automatically delivers the best value. That is often wrong.
Over-specification is a common mistake. High-end systems without matching patient volume lead to underutilization and poor returns.
Another error is ignoring detector technology. Buyers focus on modality labels like PET or SPECT, but performance differences often come from detector design.
There is also hidden double counting in market assumptions. Equipment demand is often confused with procedure growth, which does not always translate into new system purchases.
Finally, hybrid systems are treated as future-proof. In reality, rapid innovation means even hybrid platforms can become outdated faster than expected.
Practical implications by stakeholder
Healthcare providers
Must align imaging investment with actual patient mix and reimbursement stability
Need to balance clinical capability with financial sustainability
Diagnostic imaging centers
Focus on throughput and efficiency rather than maximum capability
Prioritize systems that reduce scan time and increase patient turnover
Equipment manufacturers
Need to differentiate through detector innovation and software integration
Must address buyer concerns around upgrade paths and lifecycle costs
Investors and operators
Evaluate utilization risk and regional demand variability
Focus on assets that maintain relevance across technology cycles
Regulators and policymakers
Influence adoption through reimbursement structures
Shape infrastructure readiness and compliance requirements
GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET
REPORT METRIC
DETAILS
Market Size Available
2024 - 2030
Base Year
2024
Forecast Period
2025 - 2030
CAGR
11.5%
Segments Covered
By Product, Type, Consumption, Distribution Channel and Region
Various Analyses Covered
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities
Regional Scope
North America, Europe, APAC, Latin America, Middle East & Africa
Key Companies Profiled
GE HealthCare, Siemens Healthineers
Philips Healthcare, Canon Medical Systems
United Imaging Healthcare, Fujifilm Holdings
Mediso, Bruker, Digirad Corporation, Neusoft Medical Systems
Market Segmentation
Nuclear Medicine Imaging Equipment Market – By Modality
• Introduction/Key Findings
• Single Photon Emission Computed Tomography (SPECT) Systems
• Positron Emission Tomography (PET) Systems
• Hybrid SPECT/CT Systems
• Hybrid PET/CT Systems
• Hybrid PET/MRI Systems
• Others
• Y-O-Y Growth Trend & Opportunity Analysis
In 2025, the Hybrid PET/CT Systems segment dominates the market due to their widespread use in oncology and ability to provide both functional and anatomical imaging.
However, Hybrid PET/MRI Systems are expected to be the fastest-growing segment during the forecast period as they offer superior soft tissue imaging and reduced radiation exposure.
Nuclear Medicine Imaging Equipment Market – By Detector Type
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa
In 2025, North America holds the dominant share of the Nuclear Medicine Imaging Equipment Market due to advanced healthcare infrastructure and high adoption of imaging technologies.
However, Asia-Pacific is expected to be the fastest-growing region during the forecast period due to expanding healthcare infrastructure and increasing demand for advanced diagnostic imaging.
Latest Market News
March 2026 — Siemens Healthineers introduced next-generation PET/CT imaging systems designed to improve diagnostic accuracy.
January 2026 — GE HealthCare launched advanced nuclear imaging solutions with enhanced detector technologies.
November 2025 — Philips expanded its hybrid imaging portfolio with new PET/MRI systems.
September 2025 — Canon Medical introduced new SPECT imaging systems designed for improved performance.
July 2025 — United Imaging Healthcare expanded its nuclear imaging equipment offerings for global markets.
Key Players
GE HealthCare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
United Imaging Healthcare
Fujifilm Holdings
Mediso
Bruker
Digirad Corporation
Neusoft Medical Systems
To Learn more about this report,
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Key Market Insights:
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
Global Automotive Lighting Market Drivers:
Using cutting-edge technology to illuminate the road, safety serves as a guiding light.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Beyond Performance-Based Luxuries Redefined by Light.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
Fuel Efficiency Takes the Lead: Illuminating Sustainability
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
To Learn more about this report,
Global Automotive Lighting Market Restraints and Challenges:
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
Global Automotive Lighting Market Opportunities:
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
AUTOMOTIVE LIGHTING MARKET REPORT COVERAGE:
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Application
Exterior Lighting
Interior Lighting
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
Global Automotive Lighting Market Segmentation: By Technology
Halogen
LED (Light-Emitting Diode)
Xenon
Emerging Technologies
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Global Automotive Lighting Market Segmentation: By Vehicle Type
Passenger Cars
Commercial Vehicles
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Global Automotive Lighting Market Segmentation: By Sales Channel
OEM (Original Equipment Manufacturers)
Aftermarket
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
To Learn more about this report,
Global Automotive Lighting Market Segmentation: By Region
North America
Asia-Pacific
Europe
South America
Middle East and Africa
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
COVID-19 Impact Analysis on the Global Automotive Lighting Market:
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
Recent Trends and Developments in the Global Automotive Lighting Market:
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
Key Players:
AMS Osram
Cree
Hella
Hyundai Mobis
Koito
Luminus Devices
Magneti Marelli
Osram Licht AG
Stanley Electric
Valeo
Chapter 1.GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET– SCOPE & METHODOLOGY 1.1. Market Segmentation
1.2. Scope, Assumptions & Limitations
1.3. Research Methodology
1.4. Primary End-user Application .
1.5. Secondary End-user Application Chapter 2. GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET– EXECUTIVE SUMMARY 2.1. Market Size & Forecast – (2025 – 2030) ($M/$Bn)
2.2. Key Trends & Insights
2.2.1. Demand Side
2.2.2. Supply Side
2.3. Attractive Investment Propositions
2.4. COVID-19 Impact Analysis Chapter 3. GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET– COMPETITION SCENARIO 3.1. Market Share Analysis & Company Benchmarking
3.2. Competitive Strategy & Development Scenario
3.3. Competitive Pricing Analysis
3.4. Supplier-Distributor Analysis Chapter 4. GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET- ENTRY SCENARIO 4.1. Regulatory Scenario
4.2. Case Studies – Key Start-ups
4.3. Customer Analysis
4.4. PESTLE Analysis
4.5. Porters Five Force Model
4.5.1. Bargaining Frontline Workers Training of Suppliers
4.5.2. Bargaining Risk Analytics s of Customers
4.5.3. Threat of New Entrants
4.5.4. Rivalry among Existing Players
4.5.5. Threat of Substitutes Players
4.5.6. Threat of Substitutes Chapter 5. GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET- LANDSCAPE 5.1. Value Chain Analysis – Key Stakeholders Impact Analysis
5.2. Market Drivers
5.3. Market Restraints/Challenges
5.4. Market Opportunities Chapter 6. GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET– By Type
Introduction/Key Findings
• Cyclotron Systems
• Radiotracer Production Systems (Synthesis Modules & Hot Cells)
• Integrated Cyclotron & Radiochemistry Systems
• Compact/Low-Energy Cyclotrons
• High-Energy Cyclotrons
• Others
• Y-O-Y Growth Trend & Opportunity Analysis
Chapter7.GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET–ByApplication
Chapter 9.GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET– By End User
• Introduction/Key Findings
• Hospitals
• Diagnostic Imaging Centers
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Contract Manufacturing Organizations (CMOs)
• Others
• Y-O-Y Growth Trend & Opportunity Analysis
Chapter 10. GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET – By Geography – Market Size, Forecast, Trends & Insights 10.1. North America
10.1.1. By Country
10.1.1.1. U.S.A.
10.1.1.2. Canada
10.1.1.3. Mexico
10.1.2. By Type
10.1.3. By Application
10.1.4. By Form
10.1.5. By Infrastructure Scale
10.1.6. Countries & Segments - Market Attractiveness Analysis
10.2. Europe
10.2.1. By Country
10.2.1.1. U.K.
10.2.1.2. Germany
10.2.1.3. France
10.2.1.4. Italy
10.2.1.5. Spain
10.2.1.6. Rest of Europe
10.2.2. By Type
10.2.3. By Application
10.2.4. By Form
10.2.5. By Infrastructure Scale
10.2.6. Countries & Segments - Market Attractiveness Analysis
10.3. Asia Pacific
10.3.1. By Country
10.3.1.1. China
10.3.1.2. Japan
10.3.1.3. South Korea
10.3.1.4. India
10.3.1.5. Australia & New Zealand
10.3.1.6. Rest of Asia-Pacific
10.3.2. By Type
10.3.3. By Application
10.3.4. By Form
10.3.5. By Infrastructure Scale
10.3.6. Countries & Segments - Market Attractiveness Analysis
10.4. South America
10.4.1. By Country
10.4.1.1. Brazil
10.4.1.2. Argentina
10.4.1.3. Colombia
10.4.1.4. Chile
10.4.1.5. Rest of South America
10.4.2. By Type
10.4.3. By Application
10.4.4. By Form
10.4.5. By Infrastructure Scale
10.4.6. Countries & Segments - Market Attractiveness Analysis
10.5. Middle East & Africa
10.5.1. By Country
10.5.1.1. United Arab Emirates (UAE)
10.5.1.2. Saudi Arabia
10.5.1.3. Qatar
10.5.1.4. Israel
10.5.1.5. South Africa
10.5.1.6. Nigeria
10.5.1.7. Kenya
10.5.1.8. Egypt
10.5.1.9. Rest of MEA
10.5.2. By Type
10.5.3. By Application
10.5.4. By Form
10.5.5. By Infrastructure Scale
10.5.6. Countries & Segments - Market Attractiveness Analysis Chapter 11. GLOBAL NUCLEAR MEDICINE IMAGING EQUIPMENT MARKET– Company Profiles – (Overview, Type of Training Portfolio, Financials, Strategies & Developments)
GE HealthCare
Siemens Healthineers
Philips Healthcare
Canon Medical Systems
United Imaging Healthcare
Fujifilm Holdings
Mediso
Bruker
Digirad Corporation
Neusoft Medical Systems
Fill out the form below and our team will get back to you shortly
FAQ's
In 2025, the Global Nuclear Medicine Imaging Equipment Market was valued at approximately USD 3,965 Million and is projected to reach around USD 6,842 Million by 2030, expanding at a CAGR of about 11.5% during 2026–2030.
Key drivers include the rising prevalence of chronic diseases and advancements in hybrid imaging technologies.
Hybrid PET/CT systems currently hold the largest share.
More related reports
Get expert-driven market research reports from a leading research partner to help you navigate the future of the global industry.
Report Code: VMR-19361 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Newborn Screening Market was valued at approximately USD 6.14 Billion. It is projected to grow at a CAGR of around 7.6% during the forecast period of 2026–2030, reaching an estimated USD 8.86 Billion by 2030...
Report Code: VMR-19360 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19359 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Home Diagnostics & Self-Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41...
Report Code: VMR-19358 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Clinical Microbiology Testing Market was valued at approximately USD 9.85 Billion. It is projected to grow at a CAGR of around 7.9% during the forecast period of 2026–2030, reaching an estimated USD 14.41 Bi...
Report Code: VMR-19356 | Published Date: May 2026 | Format: Excel and PDF
In 2025, the Global Fertility Services & IVF Technology Market was valued at approximately USD 53 Billion and is projected to reach around USD 82.30 Billion by 2030, expanding at a CAGR of about 9.2% during 2026–2030.
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”
Medical Devices Company based in Europe
“We received a complex piece of work for our niche market from Virtue Market research in short period of time. I appreciate the quality and content of the final files we received. Thanks for the support”